ReviewDiabetology & metabolic syndrome2026
GLP-1 receptor agonists as multisystem therapies: from glycemic control to cardiorenal, neuroimmune, and metabolic disease.
Malek Zarei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.